The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $2,348.52 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of TWINRIX VACCINE SYRINGEML, and has a period of performance through June 10, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to...
The U.S. Defense Logistics Agency (DLA) awarded a $12,070.69 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,564,374,156 units of the TWINRIX VACCINE SYRINGEML. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the...
This contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of Twinrix vaccine syringes to the Defense Logistics Agency (DLA) worth $1,205.16. The contract is a Firm Fixed Price Delivery Order with a completion date of June 6, 2024. Amerisourcebergen, a large pharmaceutical distribution company, has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025 to provide a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,379.16 Firm Fixed Price delivery order is for the supply of Twinrix vaccine syringes. The contract has an ultimate completion date of November 7, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract (SPE2DB20D2002|SPE2DB24FL31A) worth $1,779.70 to provide the TWINRIX VACCINE SYRINGEML product. The contract has an ultimate completion date of March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $231,266.24 firm fixed price delivery order contract to provide TWINRIX VACCINE SYRINGEML. This order is part of an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $97,641.06 firm-fixed-price delivery order is for the supply of Twinrix vaccine syringes and has a completion date of December 11, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $5,215.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of the TWINRIX VACCINE SYRINGEML product, with a completion date of April 19, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $128,119.76 Firm Fixed Price delivery order is for the supply of Twinrix vaccine syringes. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the TWINRIX VACCINE SYRINGE medication. The $13,660.52 contract has a performance period through March 8, 2024 and does not include any set-aside designation. Amerisourcebergen Drug Corp has received numerous similar pharmaceutical and medical supply contracts from DLA to support military treatment programs and...